Skip to main content
Clinical Trials/CTRI/2022/02/040373
CTRI/2022/02/040373
Recruiting
未知

Clinical Utility of a Circulating Tumor Cell Based Test for Cancer Detection and Diagnosis

Datar Cancer Genetics Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Datar Cancer Genetics Private Limited
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Adult males and females, aged 18 years and above,
  • 2\.Provision of Informed Consent,
  • 3\.Willing and able to participate in the study and provide blood sample.
  • 4\.No co\-morbidities which could impair study participation or procedures,
  • 5\.No prior diagnosis of any cancer,
  • 6\.Suspected of primary malignancy of either the brain, breast, lung, prostate, pancreas, bile duct or gallbladder, and posted to undergo an invasive biopsy as part of standard diagnostic procedures.

Exclusion Criteria

  • 1\.Failure to meet Inclusion Criteria,
  • 2\.Age less than 18 years,
  • 3\.Inability to provide Informed Consent,
  • 4\.Co\-morbidities which could impair study participation or sample collection,
  • 5\.Positive for HIV / HBV / HCV,
  • 6\.Prior diagnosis of any malignancy,
  • 7\.Unable to undergo an invasive biopsy as part of standard diagnostic procedures.
  • 8\.Suspicion of hematological, lymphoid or myeloid malignancies.

Outcomes

Primary Outcomes

Not specified

Similar Trials